Startseite Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke

  • Jitender Gairolla

    Jitender Gairolla is pursuing his PhD in the Department of Neurology, PGIMER, Chandigarh, India and his research work is focused on genetic variation analysis of adipokine genes in ischemic stroke patients with extracranial and intracranial atherosclerotic disease. His other areas of interest are biomarker and antiplatelet drug discovery in the field of stroke.

    , Rupinder Kler

    Rupinder Kler received her PhD in basic medical sciences from Panjab University. Currently working as research consultant in Department of Neurology, PGIMER Chandigarh, India. Her areas of interest are pharmacogenomics and stem cell therapy for neurological disorders.

    , Manish Modi

    Manish Modi is currently working as Additional Professor in the Department of Neurology, Post graduate Institute of Medical Education & Research, Chandigarh, India. His areas of interest are Tropical Neurology, especially CNS infections and has many original research papers in Tuberculous meningitis, Neurocysticercosis, Japanese encephalitis, HIV, etc.

    und Dheeraj Khurana

    Dheeraj Khurana is in charge of the stroke program and Professor of Neurology at the Post Graduate Institute of Medical Education and Research, Chandigarh, India. His areas of interest are acute stroke management, thrombolysis and intracranial atherosclerotic disease. He has been actively involved in research on carotid atherosclerotic disease, antiplatelet resistance and intracerebral hemorrhages. Currently he is the President of the Indian stroke association and vice president of World NCD federation.

    ORCID logo EMAIL logo
Veröffentlicht/Copyright: 25. Januar 2017
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Stroke is a multifactorial disease contributing to significant noncommunicable disease burden in developing countries. Risk of stroke is largely a consequence of morbidities of diabetes, obesity, hypertension, and heart diseases. Incidence of stroke is directly proportional to body mass index. Adipose tissue stores energy as well as acts as an active endocrine organ, which secretes numerous humoral factors. Adiponectin and leptin are the commonest adipocytokines and have been invariably linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of stroke. Leptin and adiponectin mediate proatherogenic and antiatherogenic responses, respectively, and hence, determining the plasma or serum levels of leptin and adiponectin alone or in combination may act as a novel prognostic biomarker for inflammation and atherosclerosis in stroke. This review addresses leptin- and adiponectin-mediated inflammatory mechanism in ischemic stroke and their potential as therapeutic targets.

About the authors

Jitender Gairolla

Jitender Gairolla is pursuing his PhD in the Department of Neurology, PGIMER, Chandigarh, India and his research work is focused on genetic variation analysis of adipokine genes in ischemic stroke patients with extracranial and intracranial atherosclerotic disease. His other areas of interest are biomarker and antiplatelet drug discovery in the field of stroke.

Rupinder Kler

Rupinder Kler received her PhD in basic medical sciences from Panjab University. Currently working as research consultant in Department of Neurology, PGIMER Chandigarh, India. Her areas of interest are pharmacogenomics and stem cell therapy for neurological disorders.

Manish Modi

Manish Modi is currently working as Additional Professor in the Department of Neurology, Post graduate Institute of Medical Education & Research, Chandigarh, India. His areas of interest are Tropical Neurology, especially CNS infections and has many original research papers in Tuberculous meningitis, Neurocysticercosis, Japanese encephalitis, HIV, etc.

Dheeraj Khurana

Dheeraj Khurana is in charge of the stroke program and Professor of Neurology at the Post Graduate Institute of Medical Education and Research, Chandigarh, India. His areas of interest are acute stroke management, thrombolysis and intracranial atherosclerotic disease. He has been actively involved in research on carotid atherosclerotic disease, antiplatelet resistance and intracerebral hemorrhages. Currently he is the President of the Indian stroke association and vice president of World NCD federation.

Acknowledgments

Jitender Gairolla has been awarded a senior research fellowship from Indian Council of Medical Research (ICMR), New Delhi, India.

  1. Conflict of interest statement: None of the authors declare any conflict of interest.

References

Adya, R., Tan, B. K., and Randeva H. S. (2015). Differential effects of leptin and adiponectin in endothelial angiogenesis. J Diabetes Res. 2015, 648239.10.1155/2015/648239Suche in Google Scholar

Ahima, R.S. and Osei, S.Y. (2004). Leptin signaling. Physiol. Behav. 81, 223–241.10.1016/j.physbeh.2004.02.014Suche in Google Scholar

Aleidi, S., Issa, A., Bustanji, H., Khalil M., and Bustanji Y. (2015). Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm. J. 23, 250–256.10.1016/j.jsps.2014.11.011Suche in Google Scholar

Aprahamian, T.R. and Sam, F. (2011). Adiponectin in cardiovascular inflammation and obesity. Int. J. Inflam. 2011, 376909.10.4061/2011/376909Suche in Google Scholar

Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79–83.10.1006/bbrc.1999.0255Suche in Google Scholar

Bailleul, B., Akerblom, I., and Strosberg, A.D. (1997). The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res. 25, 2752–2758.10.1093/nar/25.14.2752Suche in Google Scholar

Bang, O.Y., Saver, J.L., Ovbiagele, B., Choi, Y.J., Yoon, S.R., and Lee, K.H. (2007). Adiponectin levels in patients with intracranial atherosclerosis. Neurology 22, 1931–1937.10.1212/01.wnl.0000263186.20988.9fSuche in Google Scholar

Beltowski, J. (2006). Leptin and atherosclerosis. Atherosclerosis 189, 47–60.10.1016/j.atherosclerosis.2006.03.003Suche in Google Scholar

Berg, A.H., Combs, T.P., Du, X., Brownlee, M., and Scherer, P.E. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947–953.10.1038/90992Suche in Google Scholar

Berg, A.H., Combs, T.P., and Scherer, P.E. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13, 84–89.10.1016/S1043-2760(01)00524-0Suche in Google Scholar

Bidulescu, A., Liu, J., Chen, Z., Hickson, D.A., Musani, S.K., Samdarshi, T.E., Fox, E.R., Taylor, H.A., and Gibbons, G.H. (2013). Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in African Americans: the Jackson Heart Study. Front. Public Health 1, 16.Suche in Google Scholar

Blumer, R.M., van Roomen, C.P., Meijer, A.J., Houben-Weerts, J.H., Sauerwein, H.P., and Dubbelhuis, P.F. (2008). Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes. Metabolism 57, 1655–1662.10.1016/j.metabol.2008.07.020Suche in Google Scholar PubMed

Bodary, P.F. and Eitzman, D.T. (2006). Adiponectin: vascular protection from the fat? Arterioscler. Thromb. Vasc. Biol. 26, 235–236.10.1161/01.ATV.0000200222.55680.dfSuche in Google Scholar PubMed

Bodles, A.M., Banga, A., Rasouli, N., Ono, F., Kern, P.A., and Owens, R.J. (2006). Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am. J. Physiol. Endocrinol. Metab. 291, E1100–E1105.10.1152/ajpendo.00187.2006Suche in Google Scholar PubMed

Bouloumie, A., Marumo, T., Lafontan, M., and Busse, R. (1999). Leptin induces oxidative stress in human endothelial cells. FASEB J. 13, 1231–1238.10.1096/fasebj.13.10.1231Suche in Google Scholar

Bouloumié, A., Curat, C.A., Sengenès, C., Lolmède, K., Alexandra M., and Busse, R. (2005). Role of Macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care 8, 347–54.10.1097/01.mco.0000172571.41149.52Suche in Google Scholar PubMed

Buechler, C., Wanninger, J., and Neumeier, M. (2010). Adiponectin receptor binding proteins—recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 584, 4280–4286.10.1016/j.febslet.2010.09.035Suche in Google Scholar PubMed

Caselli, C., D’Amico, A., Cabiati, M., Prescimone, T., Del Ry, S., and Giannessi, D. (2014). Back to the heart: the protective role of adiponectin. Pharmacol. Res. 82, 9–20.10.1016/j.phrs.2014.03.003Suche in Google Scholar PubMed

Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., and Quon, M.J. (2003). Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278, 45021–45026.10.1074/jbc.M307878200Suche in Google Scholar PubMed

Chen, M.P., Tsai, J.C., Chung, F.M., Yang, S.S., Hsing, L.L., Shin, S.J., and Lee, Y.J. (2005). Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 821–826.10.1161/01.ATV.0000157784.25920.a7Suche in Google Scholar PubMed

Chen, K., Li, F., Li, J., Cai, H., Strom, S., Bisello, A., Kelley, D.E., Friedman-Einat, M., Skibinski, G.A., McCrory, M.A. (2006). Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med. 12, 425–432.10.1038/nm1372Suche in Google Scholar PubMed

Chen, B., Liao, W.Q., Xu, N., Xu., H., Wen, J.Y., Yu, C.A., Liu, X.Y., Li, C.L., Zhao, S.M., and Campbell, W. (2009). Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 1273, 129–137.10.1016/j.brainres.2009.04.002Suche in Google Scholar

Cioffi, J.A., Shafer, A.W., Zupancic, T.J., Smith-Gbur, J., Mikhail, A., Platika, D., and Snodgrass, H.R. (1996). Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat. Med. 2, 585–589.10.1038/nm0596-585Suche in Google Scholar

Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.M., et al. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392. 398–401.10.1038/32911Suche in Google Scholar

Corsonello, A., Perticone, F., Malara, A., De Domenico, D., Loddo, S., Buemi, M., Ientile, R., and Corica, F. (2003). Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int. J. Obes. Relat. Metab. Disord. 27, 566–573.10.1038/sj.ijo.0802273Suche in Google Scholar

Deb, P., Sharma, S., and Hassan, K.M. (2010). Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17, 197–218.10.1016/j.pathophys.2009.12.001Suche in Google Scholar

Dichgans, M. (2007). Genetics of ischaemic stroke. Lancet Neurol. 6, 149–161.10.1016/S1474-4422(07)70028-5Suche in Google Scholar

Fazeli, M., Zarkesh-Esfahani, H., Wu, Z., Maamra, M., Bidlingmaier, M., Pockley, A.G., Watson, P., Matarese, G., Strasburger, C.J., and Ross, R.J. (2006). Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J. Immunol. Methods 312, 190–200.10.1016/j.jim.2006.03.011Suche in Google Scholar

Feigin, V.L., Forouzanfar, M.H., Krishnamurthi, R., Mensah, G.A., Connor, M., Bennett, D.A., Moran, A.E., Sacco, R.L., Anderson, L., Truelsen, T., et al. (2014). Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study. Lancet 383, 245–254.10.1016/S0140-6736(13)61953-4Suche in Google Scholar

Fisman, E.Z. and Tenenbaum, A. (2014). Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc. Diabetol. 13, 103.10.1186/1475-2840-13-103Suche in Google Scholar PubMed PubMed Central

Friedman, J.M. (2009). Leptin at 14 y of age: an ongoing story. Am. J. Clin. Nutr. 89, 973S–979S.10.3945/ajcn.2008.26788BSuche in Google Scholar PubMed PubMed Central

Fruhbeck, G. (2006). Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7–20.10.1042/BJ20051578Suche in Google Scholar PubMed PubMed Central

Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., and. Feingold, K.R. (1996). Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97, 2152–2157.10.1172/JCI118653Suche in Google Scholar PubMed PubMed Central

Gu, P. and Xu, A. (2013). Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev. Endocr. Metab. Disord. 14, 49–58.10.1007/s11154-012-9230-8Suche in Google Scholar PubMed

Hada, Y., Yamauchi, T., Waki, H., Tsuchida, A., Hara, K., Yago, H., Miyazaki, O., Ebinuma, H., and Kadowaki, T. (2007). Selective purification and characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun. 356, 487–493.10.1016/j.bbrc.2007.03.004Suche in Google Scholar PubMed

Hattori, Y., Nakano, Y., Hattori, S., Tomizawa, A., Inukai, K., and Kasai, K. (2008). High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett. 582, 1719–1724.10.1016/j.febslet.2008.04.037Suche in Google Scholar PubMed

Hribal, M.L., Fiorentino, T.V., and Sesti, G. (2014). Role of C reactive protein (CRP) in leptin resistance. Curr. Pharm. Des. 20, 609–615.10.2174/13816128113199990016Suche in Google Scholar PubMed PubMed Central

Hu, E., Liang, P., and Spiegelman, B.M. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697–10703.10.1074/jbc.271.18.10697Suche in Google Scholar PubMed

Hukshorn, C.J. and Saris, W.H. (2004). Leptin and energy expenditure. Curr. Opin. Clin. Nutr. Metab. Care 7, 629–633.10.1097/00075197-200411000-00007Suche in Google Scholar PubMed

Imagawa, K., Numata, Y., Katsuura, G., Sakaguchi, I., Morita, A., Kikuoka, S., Matumoto, Y., Tsuji, T., Tamaki, M., Sasakura, K., et al. (1998). Structure-function studies of human leptin. J. Biol. Chem. 273, 35245–35249.10.1074/jbc.273.52.35245Suche in Google Scholar PubMed

Isse, N., Ogawa, Y., Tamura, N., Masuzaki, H., Mori, K., Okazaki, T., Satoh, N., Shigemoto, M., Yoshimasa, Y., Nishi S., et al. (1995). Structural organization and chromosomal assignment of the human obese gene. J. Biol. Chem. 270, 27728–27733.10.1074/jbc.270.46.27728Suche in Google Scholar PubMed

Iwashima, Y., Katsuya, T., Ishikawa, K., Ouchi, N., Ohishi, M., Sugimoto, K., Fu, Y., Motone, M., Yamamoto, K., Matsuo, A., et al. (2004). Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43, 1318–1323.10.1161/01.HYP.0000129281.03801.4bSuche in Google Scholar

Jaleel, A., Aqil, S., Jaleel, S., and Jaleel, F. (2010). Adipocytokines in subjects with and without ischemic cerebrovascular disease. Acta Neurol. Belg. 110, 234–238.Suche in Google Scholar

Jin, R., Yang, G., and Li, G. (2010). Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87, 779–789.10.1189/jlb.1109766Suche in Google Scholar

Juge-Aubry, C.E., Henrichot, E., and Meier, C.A. (2005). Adipose tissue: a regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 19, 547–66.10.1016/j.beem.2005.07.009Suche in Google Scholar

Kadowaki, T. and Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439–451.10.1210/er.2005-0005Suche in Google Scholar

Kantorova, E., Chomova, M., Kurca, E., Sivak, S., Zelenak, K., Kucera, P., and Galajda, P. (2011). Leptin, adiponectin and ghrelin, new potential mediators of ischemic stroke. Neurol. Endocrinol. Lett. 32, 716–721.Suche in Google Scholar

Kantorová, E., Jesenská, Ľ., Čierny, D., Zeleňák, K., Sivák, S., Stančík, M., Galajda, P., Nosáľ, V., and Kurča, E. (2015). The intricate network of adipokines and stroke. Int. J. Endocrinol. 2015, 967698.10.1155/2015/967698Suche in Google Scholar

Kato, H., Kashiwagi, H., Shiraga, M., Tadokoro, S., Kamae, T., Ujiie, H., Honda, S., Miyata, S., Ijiri, Y., Yamamoto, J., et al. (2006). Adiponectin acts as an endogenous antithrombotic factor. Arterioscler. Thromb. Vasc. Biol. 26, 224–230.10.1161/01.ATV.0000194076.84568.81Suche in Google Scholar

Kershaw, E.E. and Flier, J.S. (2004). Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556.10.1210/jc.2004-0395Suche in Google Scholar

Kielar, D., Clark, J.S., Ciechanowicz, A., Kurzawski, G., Sulikowski, T., and Naruszewicz, M. (1998). Leptin receptor isoforms expressed in human adipose tissue. Metabolism 47, 844–847.10.1016/S0026-0495(98)90124-XSuche in Google Scholar

Kim, B.J., Lee, S.H., Ryu, W.S., Kim, C.K., and Yoon, B.W. (2012). Adipocytokines and ischemic stroke: differential associations between stroke subtypes. J. Neurol. Sci. 312, 117–122.10.1016/j.jns.2011.08.007Suche in Google Scholar PubMed

Koh, K.K., Park., S.M., and Quon, M.J. (2008). Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 117, 3238–3249.10.1161/CIRCULATIONAHA.107.741645Suche in Google Scholar PubMed PubMed Central

Konstantinides, S., Schafer, K., Koschnick, S., and Loskutoff, D.J. (2001). Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108, 1533–1540.10.1172/JCI13143Suche in Google Scholar PubMed PubMed Central

La Cava, A. and Matarese, G. (2004).The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371–379.10.1038/nri1350Suche in Google Scholar PubMed

Lago, F., Dieguez, C., Gómez-Reino, J., and Gualillo, O. (2007). Adipokines as emerging mediators of immune response and inflammation. Nat. Clin. Pract. Rheumatol. 3, 716–24.10.1038/ncprheum0674Suche in Google Scholar PubMed

Lakhan, S.E., Kirchgessner, A., and Hofer, M. (2009). Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.10.1186/1479-5876-7-97Suche in Google Scholar PubMed PubMed Central

Lam, Q.L. and Lu, L. (2007). Role of leptin in immunity. Cell. Mol. Immunol. 4, 1–13.Suche in Google Scholar

Lambertsen, K.L., Biber, K., and Finsen, B. (2012). Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood. Flow. Metab. 32, 1677–1698.10.1038/jcbfm.2012.88Suche in Google Scholar PubMed PubMed Central

Lee, C.H. and Hung, Y.J. (2015). Possible new therapeutic approach for obesity-related diseases: role of adiponectin receptor agonists. J. Diabetes Invest. 6, 264–66.10.1111/jdi.12263Suche in Google Scholar PubMed PubMed Central

Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh, J.G., Lee, J.I., and Friedman, J.M. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632–635.10.1038/379632a0Suche in Google Scholar PubMed

Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868–74.10.1038/nature01323Suche in Google Scholar PubMed

Liu, J. and Wang, L.N. (2014).Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Cochrane Database Syst. Rev. 1, CD010693.10.1002/14651858.CD010693.pub2Suche in Google Scholar PubMed

Liu, J., Butler, K.R., Buxbaum, S.G., Sung, J.H., Campbell, B.W., and Taylor, H.A. (2010). Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study. Clin. Endocrinol. (Oxf). 72, 32–37.10.1111/j.1365-2265.2009.03627.xSuche in Google Scholar PubMed PubMed Central

Lord, G.M., Matarese, G., Howard, J.K., Baker, R.J., Bloom, S.R., and Lechler, R.I. (1998). Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897–901.10.1038/29795Suche in Google Scholar PubMed

MacDougald, O.A. and Burant, C.F. (2007). The rapidly expanding family of adipokines. Cell Metab. 6, 159–161.10.1016/j.cmet.2007.08.010Suche in Google Scholar PubMed

Margetic, S., Gazzola, C., Pegg, G.G., and Hill, R.A. (2002).Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26, 1407–1433.10.1038/sj.ijo.0802142Suche in Google Scholar PubMed

Martin-Romero, C., Santos-Alvarez, J., Goberna, R., and Sanchez-Margalet, V. (2000). Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 199, 15–24.10.1006/cimm.1999.1594Suche in Google Scholar PubMed

Matarese, G. (2000). Leptin and the immune system: how nutritional status influences the immune response. Eur. Cytokine Netw. 11, 7–14.Suche in Google Scholar

Matarese, G., Moschos, S., and Mantzoros, C.S. (2005). Leptin in Immunology. J. Immunol. 174, 3137–3142.10.4049/jimmunol.174.6.3137Suche in Google Scholar PubMed

Matsubara, M., Maruoka, S., and Katayose, S. (2002). Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur. J. Endocrinol. 14, 173–180.10.1530/eje.0.1470173Suche in Google Scholar PubMed

Matsumoto, M., Ishikawa, S., and Kajii, E. (2008). Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 39, 323–328.10.1161/STROKEAHA.107.497552Suche in Google Scholar PubMed

Mertens, I., Ballaux, D., Funahashi, T., Matsuzawa, Y., Van der Planken, M., Verrijken, A., Ruige, J.B., and Van Gaal, L.F. (2005). Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation. Thromb. Haemost. 94, 1190–1195.10.1160/TH05-01-0024Suche in Google Scholar

Nakamura, Y., Ueshima, H., Okuda, N., Miura, K., Kita, Y., Okamura, T., Okayama, A., Choudhury, S.R., Rodriguez, B., Masaki, K.H., et al. (2013). Relation of serum leptin and adiponectin level to serum c-reactive protein: the INTERLIPID Study. Int. J. Vasc. Med. 2013, 601364.10.1155/2013/601364Suche in Google Scholar PubMed PubMed Central

Nakata, M., Yada, T., Soejima, N., and Maruyama, I. (1999). Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48, 426–429.10.2337/diabetes.48.2.426Suche in Google Scholar PubMed

Nakatsuji, H., Kobayashi, H., Kishida, K., Nakagawa, T., Takahashi, S., Tanaka, H., Akamatsu, S., Funahashi, T., and Shimomura, I. (2013). Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin/total adiponectin ratio. Metabolism 62, 109–120.10.1016/j.metabol.2012.06.006Suche in Google Scholar PubMed

Nishimura, M., Izumiya, Y., Higuchi, A., Shibata, R., Qiu, J., Kudo, C., Shin, H.K., Moskowitz, M.A., and Ouchi, N. (2008). Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117, 216–223.10.1161/CIRCULATIONAHA.107.725044Suche in Google Scholar PubMed

Norata, G.D., Raselli, S., Grigore, L., Garlaschelli, K., Dozio, E., Magni, P., and Catapano, A.L. (2007). Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38, 2844–2846.10.1161/STROKEAHA.107.485540Suche in Google Scholar PubMed

Ogawa, Y., Masuzaki, H., Isse, N., Okazaki, T., Mori, K., Shigemoto, M., Satoh, N., Tamura, N., Hosoda, K., and Yoshimasa, Y. (1995). Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J. Clin. Invest. 96, 1647–1652.10.1172/JCI118204Suche in Google Scholar PubMed PubMed Central

Ohashi, K., Ouchi, N., and Matsuzawa, Y. (2012). Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94, 2137–2142.10.1016/j.biochi.2012.06.008Suche in Google Scholar PubMed

Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013). A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493–499.10.1038/nature12656Suche in Google Scholar PubMed

Ouchi, N. and Walsh, K. (2007). Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380, 24–30.10.1016/j.cca.2007.01.026Suche in Google Scholar PubMed PubMed Central

Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473–2476.10.1161/01.CIR.100.25.2473Suche in Google Scholar PubMed

Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057–1063.10.1161/01.CIR.103.8.1057Suche in Google Scholar PubMed

Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., et al. (2003). Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671–674.10.1161/01.CIR.0000055188.83694.B3Suche in Google Scholar PubMed

Ouedraogo, R., Wu, X., Xu, S.Q., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R., and Goldstein, B.J. (2006). Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840–1846.10.2337/db05-1174Suche in Google Scholar

Pajvani, U.B., Du, X., Combs, T.P., Berg, A.H., Rajala, M.W., Schulthess, T., Engel, J., Brownlee, M., and Scherer, P.E. (2003). Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J. Biol. Chem. 278, 9073–9085.10.1074/jbc.M207198200Suche in Google Scholar

Procaccini, C., Jirillo, E., and Matarese, G. (2012). Leptin as an immunomodulator. Mol. Aspects Med. 33, 35–45.10.1016/j.mam.2011.10.012Suche in Google Scholar

Prugger, C., Luc, G., Haas, B., Arveiler, D., Machez, E., Ferrieres, J., Ruidavets, J.B., Bingham, A., Montaye, M., Amouyel, P., et al. (2012). Adipocytokines and the risk of ischemic stroke: the PRIME Study. Ann. Neurol. 71, 478–486.10.1002/ana.22669Suche in Google Scholar

Rajpathak, S.N., Kaplan, R.C., Wassertheil-Smoller, S., Cushman, M., Rohan, T.E., McGinn, A.P., Wang, T., Strickler, H.D., Scherer, P.E., Mackey, R., et al. (2011). Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women’s Health Initiative. Stroke 42, 1813–1820.10.1161/STROKEAHA.110.607853Suche in Google Scholar

Romero, JR., Morris, J., and Pikula, A. (2008). Stroke prevention: modifying risk factors. Ther. Adv. Cardiovasc. Dis. 2, 287–303.10.1177/1753944708093847Suche in Google Scholar

Romero-Corral, A., Sierra-Johnson, J., Lopez-Jimenez, F., Thomas, R.J., Singh, P., Hoffmann, M., Okcay, A., Korinek, J., Wolk, R., and Somers, V.K. (2008). Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat. Clin. Pract. Cardiovasc. Med. 5, 418–425.10.1038/ncpcardio1218Suche in Google Scholar

Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S.M., Ho, M., Howard, V., Kissela, B., et al., American Heart Association Statistics and S. Stroke Statistics. (2008). Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25–e146.Suche in Google Scholar

Saito, K., Tobe, T., Minoshima, S., Asakawa, S., Sumiya, J., Yoda, M., Nakano, Y., Shimizu, N., and Tomita, M. (1999). Organization of the gene for gelatin-binding protein (GBP28). Gene 229, 67–73.10.1016/S0378-1119(99)00041-4Suche in Google Scholar

Sanchez-Margalet, V., Martin-Romero, C., Santos-Alvarez, J., Goberna, R., Najib, S., and Gonzalez-Yanes, C. (2003). Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin. Exp. Immunol. 133, 11–19.10.1046/j.1365-2249.2003.02190.xSuche in Google Scholar PubMed PubMed Central

Saxena, N.K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., and Anania, F.A. (2007). Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 67, 2497–2507.10.1158/0008-5472.CAN-06-3075Suche in Google Scholar PubMed PubMed Central

Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H.F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746–26749.10.1074/jbc.270.45.26746Suche in Google Scholar

Schneiderman, J., Schaefer, K., Kolodgie, F.D., Savion, N., Kotev-Emeth, S., Dardik, R., Simon, A.J., Halak, M., Pariente, C., Engelberg, I., et al. (2012). Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli. J. Am. Heart. Assoc. 1, e001727.10.1161/JAHA.112.001727Suche in Google Scholar

Shamsuzzaman, A.S., Winnicki, M., Wolk, R., Svatikova, A., Phillips, B.G., Davison, D.E., Berger, P.B., and Somers, V.K. (2004). Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109, 2181–2185.10.1161/01.CIR.0000127960.28627.75Suche in Google Scholar

Shapiro, L. and Scherer, P.E. (1998). The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335–338.10.1016/S0960-9822(98)70133-2Suche in Google Scholar

Shibata, R., Murohara, T., and Ouchi, N. (2012). Protective role of adiponectin in cardiovascular disease. Curr. Med. Chem. 19, 5459–5466.10.2174/092986712803833164Suche in Google Scholar PubMed

Shimada, K., Miyazaki, T., and Daida, H. (2004).Adiponectin and atherosclerotic disease. Clin. Chim. Acta 344, 1–12.10.1016/j.cccn.2004.02.020Suche in Google Scholar PubMed

Siitonen, N., Pulkkinen, L., Lindstrom, J., Kolehmainen, M., Eriksson, J.G., Venojarvi, M., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Tuomilehto, J., and Uusitupa, M. (2011). Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med. Genet. 12, 5.10.1186/1471-2350-12-5Suche in Google Scholar PubMed PubMed Central

Singh, P., Hoffmann, M., Wolk, R., Shamsuzzaman, A.S., and Somers, V.K. (2007). Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, e302–e307.10.1161/ATVBAHA.107.148353Suche in Google Scholar PubMed

Soderberg, S., Ahren, B., Stegmayr, B., Johnson, O., Wiklund, P.G., Weinehall, L., Hallmans, G., and Olsson, T. (1999). Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 30, 328–337.10.1161/01.STR.30.2.328Suche in Google Scholar PubMed

Soderberg, S., Stegmayr, B., Ahlbeck-Glader, C., Slunga-Birgander, L., Ahren, B., and Olsson, T. (2003). High leptin levels are associated with stroke. Cerebrovasc. Dis. 15, 63–69.10.1159/000067128Suche in Google Scholar PubMed

Soderberg, S., Stegmayr, B., Stenlund, H., Sjostrom, L.G., Agren, A., Johansson, L., Weinehall, L., and Olsson, T. (2004). Leptin, but not adiponectin, predicts stroke in males. J. Intern. Med. 256, 128–136.10.1111/j.1365-2796.2004.01351.xSuche in Google Scholar

Stott, D.J., Welsh, P., Rumley, A., Robertson, M., Ford, I., Sattar, N., Westendorp, R.G., Jukema, J.W., Cobbe, S.M., and Lowe, G.D. (2009). Adipocytokines and risk of stroke in older people: a nested case-control study. Int. J. Epidemiol. 38, 253–261.10.1093/ije/dyn215Suche in Google Scholar

Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., and Haring, H. (2002). Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51, 37–41.10.2337/diabetes.51.1.37Suche in Google Scholar

Suk, S.H., Sacco, R.L., Boden-Albala, B., Cheun, J.F., Pittman, J.G., Elkind, M.S., Paik, M.C., and S. Northern Manhattan Stroke. (2003). Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 34, 1586–1592.10.1161/01.STR.0000075294.98582.2FSuche in Google Scholar

Sweeney, G. (2010). Cardiovascular effects of leptin. Nat. Rev. Cardiol. 7, 22–29.10.1038/nrcardio.2009.224Suche in Google Scholar

Takahashi, M., Arita, Y., Yamagata, K., Matsukawa, Y., Okutomi, K., Horie, M., Shimomura, I., Hotta, K., Kuriyama, H., Kihara, S., et al. (2000). Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord. 24, 861–868.10.1038/sj.ijo.0801244Suche in Google Scholar

Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., et al. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–1271.10.1016/0092-8674(95)90151-5Suche in Google Scholar

Tian, L., Luo, N., Klein, R.L., Chung, B.H., Garvey, W.T., and Fu, Y. (2009). Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 202, 152–161.10.1016/j.atherosclerosis.2008.04.011Suche in Google Scholar PubMed PubMed Central

Vaisse, C., Halaas, J.L., Horvath, C.M., Darnell, J.E., Jr., Stoffel, M., and Friedman, J.M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95–97.10.1038/ng0996-95Suche in Google Scholar PubMed

Van Gaal, L.F., Mertens, I.L., and De Block, C.E. (2006). Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880.10.1038/nature05487Suche in Google Scholar PubMed

Wannamethee, S.G., Shaper, A.G., Whincup, P.H., Lennon, L., and Sattar, N. (2013). Adiposity, adipokines, and risk of incident stroke in older men. Stroke 44, 3–8.10.1161/STROKEAHA.112.670331Suche in Google Scholar PubMed

Wong, G.W., Wang, J., Hug, C., Tsao, T.S., and Lodish, H.F. (2004). A family of Acrp30/adiponectin structural and functional paralogs. Proc. Natl. Acad. Sci. USA 101, 10302–10307.10.1073/pnas.0403760101Suche in Google Scholar PubMed PubMed Central

Wozniak, S.E., Gee, L.L., Wachtel, M.S., and Frezza, E.E. (2009). Adipose tissue: the new endocrine organ? A review article. Digest. Dis. Sci. 54, 1847–1856.10.1007/s10620-008-0585-3Suche in Google Scholar PubMed

Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941–946.10.1038/90984Suche in Google Scholar PubMed

Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288–1295.10.1038/nm788Suche in Google Scholar PubMed

Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762–769.10.1038/nature01705Suche in Google Scholar PubMed

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432.10.1038/372425a0Suche in Google Scholar PubMed

Zhu, W., Cheng, K.K., Vanhoutte, P.M., Lam, K.S., and Xu, A. (2008). Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin. Sci. (Lond). 114, 361–374.10.1042/CS20070347Suche in Google Scholar PubMed

Received: 2016-9-2
Accepted: 2016-11-30
Published Online: 2017-1-25
Published in Print: 2017-4-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 2.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/revneuro-2016-0055/html
Button zum nach oben scrollen